Arteriovenous Malformation clinical trials at UCSD
2 research studies open to eligible people
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
open to eligible people ages 18 years and up
This is a 2-part study evaluating ATV-1601 in participants with moderate to severe HHT. Part 1 is a randomized, double-blind, placebo-controlled study evaluating 3 dosing regimens of ATV-1601. Patients completing Part 1 may participate in the Part 2 open-label extension to receive ATV-1601.
San Diego, California and other locations
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
open to eligible people ages 18 years and up
In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS for intracranial lesions, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain SRS and help create interventions that preserve cognitive-function in patients with intracranial lesions.
San Diego, California
Our lead scientists for Arteriovenous Malformation research studies include Jona Hattangadi-Gluth, MD.
Last updated: